We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$906M
AUM Growth
+$185M
Cap. Flow
+$148M
Cap. Flow %
16.31%
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.7M
2
DB icon
Deutsche Bank
DB
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
COR icon
Cencora
COR
+$13.9M
5
OCR
OMNICARE INC
OCR
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Consumer Discretionary 11.57%
3 Healthcare 7.92%
4 Utilities 7.88%
5 Materials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTA icon
1
Ulta Beauty
ULTA
$21.8B
$23.6M 2.61%
156,613
+52,980
+51% +$7.33M
ELV icon
2
Elevance Health
ELV
$81.5B
$23.1M 2.55%
+149,517
New +$21.3M
AN icon
3
AutoNation
AN
$7.7B
$22.7M 2.51%
353,183
+353,125
+608,836% +$21.6M
DAL icon
4
Delta Air Lines
DAL
$56.7B
$22.5M 2.49%
501,301
+498,114
+15,630% +$23.1M
VZ icon
5
Verizon
VZ
$197B
$22.4M 2.47%
459,636
+441,655
+2,456% +$21.3M
HD icon
6
Home Depot
HD
$337B
$22.3M 2.46%
196,625
+59,918
+44% +$6.61M
JBHT icon
7
JB Hunt Transport Services
JBHT
$25.9B
$22.3M 2.46%
+261,223
New +$21.9M
PEG icon
8
Public Service Enterprise Group
PEG
$38.7B
$22.2M 2.45%
+530,159
New +$22.1M
PCAR icon
9
PACCAR
PCAR
$70.5B
$22.2M 2.45%
526,485
+523,581
+18,030% +$22.2M
PNW icon
10
Pinnacle West Capital
PNW
$12.4B
$22.1M 2.44%
347,415
+151,698
+78% +$10.1M
AGN
11
DELISTED
Allergan plc
AGN
$22M 2.43%
74,025
+73,863
+45,594% +$21.1M
LOW icon
12
Lowe's Companies
LOW
$121B
$22M 2.43%
296,047
+97,643
+49% +$7M
CLX icon
13
Clorox
CLX
$12B
$22M 2.43%
+199,322
New +$21.6M
EXPD icon
14
Expeditors International
EXPD
$22.3B
$22M 2.43%
+456,586
New +$21M
CVS icon
15
CVS Health
CVS
$135B
$21.9M 2.42%
212,570
+71,612
+51% +$7.25M
TXN icon
16
Texas Instruments
TXN
$248B
$21.9M 2.41%
382,589
+140,585
+58% +$7.9M
VMC icon
17
Vulcan Materials
VMC
$36.8B
$21.8M 2.41%
259,002
+258,999
+8,633,300% +$20M
SHW icon
18
Sherwin-Williams
SHW
$83.5B
$21.8M 2.41%
229,914
+74,052
+48% +$6.9M
WEC icon
19
WEC Energy
WEC
$36.3B
$21.7M 2.4%
+438,756
New +$22.9M
AVGO icon
20
Broadcom
AVGO
$1.76T
$21.6M 2.38%
+1,700,460
New +$19.5M
RHI icon
21
Robert Half
RHI
$4.11B
$21.6M 2.38%
356,519
+356,510
+3,961,222% +$21.4M
UAL icon
22
United Airlines
UAL
$38.8B
$21.5M 2.37%
319,089
+318,711
+84,315% +$21.6M
TSN icon
23
Tyson Foods
TSN
$21.5B
$20.5M 2.27%
536,192
+527,253
+5,898% +$21.1M
UNP icon
24
Union Pacific
UNP
$174B
$20.1M 2.22%
185,361
+79,093
+74% +$9.28M
RIG icon
25
PUT
Transocean
RIG
$5.48B
$19.4M 2.14%
14,198
+7,012
+98% +$114K

Similar funds

Exane Derivatives's Q1 2015 Portfolio in Review

As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Exane Derivatives deployed $148M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.

  • Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
  • Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
  • Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
  • Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
  • Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.